These tau polymorphs are hypothesized to underlie the pathological and clinical heterogeneity observed across tauopathies, including AD, progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB).24, 25, 26. The gene discussed is MAPT; the disease is tauopathy.